B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 800 KRW -0.14%
Market Cap: 117.7B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

Bio-FD&C Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio-FD&C Co Ltd
Capital Expenditures Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Capital Expenditures
-â‚©2.3B
CAGR 3-Years
-7%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Capital Expenditures
-â‚©350.4B
CAGR 3-Years
15%
CAGR 5-Years
-8%
CAGR 10-Years
-13%
SK Bioscience Co Ltd
KRX:302440
Capital Expenditures
-â‚©50.3B
CAGR 3-Years
-70%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Capital Expenditures
-â‚©34.1B
CAGR 3-Years
8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Capital Expenditures
-â‚©27.5B
CAGR 3-Years
11%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Capital Expenditures
-â‚©33.4B
CAGR 3-Years
-35%
CAGR 5-Years
-28%
CAGR 10-Years
N/A

See Also

What is Bio-FD&C Co Ltd's Capital Expenditures?
Capital Expenditures
-2.3B KRW

Based on the financial report for Dec 31, 2023, Bio-FD&C Co Ltd's Capital Expenditures amounts to -2.3B KRW.

What is Bio-FD&C Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-16%

Over the last year, the Capital Expenditures growth was -936%. The average annual Capital Expenditures growth rates for Bio-FD&C Co Ltd have been -7% over the past three years , -16% over the past five years .

Back to Top